Dr. Mansell’s 30-year career has spanned development of small molecules and biologics, resulting in nine successful approvals.
Category: News
AAV Gene Therapy Pioneer Jude Samulski Develops Proprietary Regulated Gene Editing System
Technology brings together benefits of AAV and CRISPR while minimizing negative effects that occur during gene editing.
AskBio Appoints Tim Trost as Chief Financial Officer
Trost is a highly accomplished CFO with more than 25 years of experience building, managing and financing emerging life sciences companies.
AskBio Acquires BrainVectis to Expand its Clinical Pipeline for Neurodegenerative Diseases
Acquisition adds Huntington’s disease gene therapy candidate to AskBio’s clinical program and provides access to pipeline for additional indications.
Don Haut, PhD, Joins AskBio as Chief Business Officer
Dr. Haut brings more than two decades of healthcare experience to AskBio and will lead its business development strategy and execution.
AskBio Enters Research Collaboration and Licensing Agreement with University of North Carolina (UNC) for Angelman Syndrome
Collaboration builds upon preclinical research that demonstrates potential for gene therapy to correct UBE3A gene deficiency.
Tim Kelly Joins AskBio as President of Manufacturing to Lead AAV Vector Production for Gene Therapy
Kelly to oversee all manufacturing functions at AskBio and Viralgen and lead clinical- and commercial-scale production of AAV vectors for gene therapy.
CYTOO and AskBio Enter into Research Agreement to Screen Gene Therapy Candidates for Rare Muscle Disorder
The companies will work together to develop an AAV-based screening platform derived from patient cells, with the goal to select a preclinical candidate.
AskBio Appoints Anna Tretiakova, PhD, as Senior Vice President of Product Development
AAV industry veteran Anna Tretiakova, PhD, has joined AskBio as SVP, Product Development to lead preclinical translational research.
AskBio Launches AskFirst™ Patient Advocacy Program to Educate and Support Participants in Gene Therapy Clinical Trials
AskBio today introduced AskFirst™, its patient advocacy program for patients and their families, and announced that Matthew Alsante will lead the program.
